 |
Articles: Chemotherapy/Oncology |
Prior Articles
Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy
Critical Reviews in Oncology/Hematology, 09/17/09
Bevacizumab: Monoclonal antibody approved for the treatment of metastatic renal cell carcinoma in combination with interferon alfa
Formulary, 09/17/09
Free full text
The use of nilotinib or dasatinib after failure to two prior tyrosine kinase inhibitors (TKI): long-term follow-up
Blood, 09/17/09 Clinical pharmacokinetics of tyrosine kinase inhibitors
Cancer Treatment Reviews, 09/17/09 High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses
Journal of Clinical Oncology, 09/16/09 Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
British Journal of Cancer, 09/16/09
Exclusive Author Commentary Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
British Journal of Cancer, 09/16/09 Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin
British Journal of Cancer, 09/16/09 Combined Thermo-Chemotherapy for Recurrent Bladder Cancer After Bacillus Calmette-Guerin
The Journal of Urology, 09/16/09 Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature
Journal of Medical Case Reports, 09/16/09
Free full text
A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
Clinical Cancer Research, 09/15/09 Trabectedin: an anticancer drug from the sea
Expert Opinion in Pharmacotherapy, 09/14/09 Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
Therapeutics and Clinical Risk Management, 09/14/09
Free full text
Revew Article
Renal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2
American Journal of Health-System Pharmacy, 09/14/09 No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications
Cancer Epidemiology, Biomarkers & Prevention, 09/14/09 CYP1B1 genotype and risk of cardiovascular disease, pulmonary disease, and cancer in 50 000 individuals
Pharmacogenetics and genomics, 09/14/09 Antidepressant use and colorectal cancer risk
Pharmacoepidemiology and Drug Safety, 09/11/09 Recommendations on current approach to gastric cancer
Clinical and Translational Oncology, 09/11/09 Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study
Anti-Cancer Drugs, 09/11/09 Gemcitabine induced digital ischaemia and necrosis
European Journal of Cancer Care, 09/11/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
